Carl Zeiss Meditec AG (AFX.XETRA): Strategic Transformation, Competitive Resilience, and Valuation Analysis episode artwork

EPISODE · Jul 29, 2026 · 38 MIN

Carl Zeiss Meditec AG (AFX.XETRA): Strategic Transformation, Competitive Resilience, and Valuation Analysis

from The Gemini Brief - Investment Deep Dives · host Lukasz Tomicki and LRT Capital Management LLC

Slide Deck 1. BUSINESS MODEL & COMPETITIVE ADVANTAGE Carl Zeiss Meditec AG (CZM), a subsidiary of the venerable Carl Zeiss Foundation, operates at the intersection of precision optics, digital workflow solutions, and therapeutic intervention. While often categorized simply as a medical device manufacturer, a granular analysis of its business model reveals a company in the […]

Episode metadata supplied by the publisher feed · Published Jul 29, 2026

Embed this episode

NOW PLAYING

Carl Zeiss Meditec AG (AFX.XETRA): Strategic Transformation, Competitive Resilience, and Valuation Analysis

0:00 38:55

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Gemini Brief - Investment Deep Dives?

This episode is 38 minutes long.

When was this The Gemini Brief - Investment Deep Dives episode published?

This episode was published on July 29, 2026.

Can I download this The Gemini Brief - Investment Deep Dives episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!